| Date | Form | Description | Docs | XBRL | Pages |
| 08/27/13 | ARS | Annual report to security holders |
|
108 | |
| 01/29/13 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
244 |
| 01/30/12 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
94 |
| 02/14/11 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
102 | |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 | |
| 06/29/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
81 | |
| 03/10/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
80 | |
| 01/29/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
121 | |
| 01/16/09 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/15/09 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 |
Latest News & Events
Anixa Biosciences to Host Conference Call to Discuss Plans for 2020
Read More...Anixa Biosciences Provides Update on CAR-T Program
Read More...Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.